0001192482-14-000228.txt : 20141110
0001192482-14-000228.hdr.sgml : 20141110
20141110120757
ACCESSION NUMBER: 0001192482-14-000228
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141030
FILED AS OF DATE: 20141110
DATE AS OF CHANGE: 20141110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Paratek Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001178711
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330960223
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 KNEELAND STREET
STREET 2: 6TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02111
BUSINESS PHONE: (617) 275-0040
MAIL ADDRESS:
STREET 1: 75 KNEELAND STREET
STREET 2: 6TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02111
FORMER COMPANY:
FORMER CONFORMED NAME: Transcept Pharmaceuticals Inc
DATE OF NAME CHANGE: 20090130
FORMER COMPANY:
FORMER CONFORMED NAME: NOVACEA INC
DATE OF NAME CHANGE: 20020724
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Danish BioVenture General Partner ApS
CENTRAL INDEX KEY: 0001624455
STATE OF INCORPORATION: G7
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36066
FILM NUMBER: 141207478
BUSINESS ADDRESS:
STREET 1: C/O GORRISSEN FEDERSPIEL,
STREET 2: H.C. ANDERSENS BOULEVARD 12
CITY: COPENHAGEN
STATE: G7
ZIP: 000000
BUSINESS PHONE: 617 502 6538
MAIL ADDRESS:
STREET 1: C/O GORRISSEN FEDERSPIEL,
STREET 2: H.C. ANDERSENS BOULEVARD 12
CITY: COPENHAGEN
STATE: G7
ZIP: 000000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: K/S Danish BioVenture
CENTRAL INDEX KEY: 0001623677
STATE OF INCORPORATION: G7
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36066
FILM NUMBER: 141207479
BUSINESS ADDRESS:
STREET 1: C/O GORRISSEN FEDERSPIEL, H.C.
STREET 2: ANDERSENS BOULEVARD 12
CITY: COPENHAGEN
STATE: G7
ZIP: 00000
BUSINESS PHONE: (617) 502-6538
MAIL ADDRESS:
STREET 1: C/O GORRISSEN FEDERSPIEL, H.C.
STREET 2: ANDERSENS BOULEVARD 12
CITY: COPENHAGEN
STATE: G7
ZIP: 00000
3
1
edgar.xml
PRIMARY DOCUMENT
X0206
3
2014-10-30
0
0001178711
Paratek Pharmaceuticals, Inc.
PRTK
0001623677
K/S Danish BioVenture
12 H.C. ANDERSENS BLVD
COPENHAGEN, DENMARK
0
0
1
0
0001624455
Danish BioVenture General Partner ApS
12 H.C. ANDERSENS BLVD
COPENHAGEN, DENMARK
0
0
1
0
Common Stock
633243
D
Common Stock
633243
I
By Danish BV
Warrant (Right to Purchase)
.15
2014-04-18
2021-04-18
Common Stock
2329
D
Warrant (Right to Purchase)
.15
2014-04-18
2021-04-18
Common Stock
2329
I
By Danish BV
The Reporting Persons are part of a "group" as defined in Rule 13d-5 promulgated under the Securities Exchange Act of 1934, as amended, with the following entities and individuals: Omega Fund III, L.P.; Omega Fund III GP, L.P.; Omega Fund III GP, Ltd.; Omega Fund IV, L.P.; Omega Fund IV GP, L.P.; Omega Fund IV GP Manager, Ltd.; Omega Fund Management Limited; Sigma Holding Company; and Otello Stampacchia. This group beneficially owns, in the aggregate, 2,138,872 shares of common stock of the issuer and warrants to purchase an additional 6,412 shares of common stock of the issuer.
The reported securities are held in the name of K/S Danish BioVenture ("Danish BV"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein.
The reported securities are beneficially owned by Danish BioVenture General Partner ApS ("Danish BV GP"), as the general partner of Danish BV. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein.
/s/ Richard Lim, authorized signatory of each Reporting Person
2014-11-10